FONT-SIZE Plus   Neg

Supernus Pharmaceuticals Prices Its IPO In The Range Of $12-$14 Per Share

Supernus Pharmaceuticals Wednesday announced that it has filed Form S-1 with the Securities and Exchange Commission or the SEC revealing the pricing of its initial public offering for 5,769,000 shares of common stock.

The company revealed that it anticipates to price the initial public offering to be between $12.00 and $14.00 per share of common stock.

The company further added that it has granted the underwriters an option to purchase up to 865,350 additional shares of common stock to cover over-allotments.

The company stated that itsd shares would be listed on the Nasdaq Global Market under the symbol "SUPN."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
It looks like 2016 is going to be a relatively lackluster year in terms of new drug approvals. Only 18 new molecular entity drugs have been approved year-to-date compared to 32 approved during the same time frame last year. Apple Inc. plans to launch a new guide for Apple TV during a product event in California today, according to Recode. While major video partners have signed up to be a part of the new Apple TV guide, Netflix Inc. will reportedly not be participating. Wal-Mart Stores Inc. is gearing up for the upcoming holiday season by deploying an army of Holiday Helpers to help customers get through the checkout process faster during the busy period. The retailer has also increased the amount of products available through its Pickup service, lowered the price on thousand of items, and plans to expand the online assortment in the coming months.
comments powered by Disqus
Follow RTT